Third Point took new stakes in Tesla (NASDAQ:TSLA), with 400K shares, CVS Health (NYSE:CVS), with 1.58M shares, and ...
CV Sciences Q3 2024 financial results: stable $3.9M revenue, improved 46% gross margin, new products, and nearing cash flow break-even.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback